Equity and Stock-Based Compensation - Summary of Stock Option Activity (Details) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
| Options | |||
| Outstanding at end of period | 589,341 | ||
| Stock Options | |||
| Options | |||
| Outstanding at beginning of period | 608,269 | 696,665 | 1,068,665 |
| Granted | 135,500 | 204,000 | 32,500 |
| Exercised | (124,475) | (241,320) | (160,375) |
| Forfeited/expired | (29,953) | (51,076) | (244,125) |
| Outstanding at end of period | 589,341 | 608,269 | 696,665 |
| Exercisable at end of period | 358,343 | 403,853 | 611,542 |
| Weighted average grant-date fair value of options granted during the period | $ 6.39 | $ 3.33 | $ 2.89 |
| Weighted Average Exercise Price | |||
| Outstanding at beginning of period | 6.48 | 7.00 | 7.04 |
| Granted | 12.80 | 6.25 | 5.34 |
| Exercised | 5.78 | 6.40 | 5.47 |
| Forfeited/expired | 6.92 | 13.01 | 7.94 |
| Outstanding at end of period | 8.06 | 6.48 | 7.00 |
| Exercisable at end of period | $ 6.92 | $ 6.87 | $ 7.19 |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average price of options that were either forfeited or expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|